Get the app
US › Healthcare

Bluejay Diagnostics Inc (BJDX)

US · Healthcare · Medical Devices

$0.74-4.36%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-2.3M
EPS
$-1.12

Key statistics

Market cap
$3.7M
Forward P/E
0.0
P/B
0.11
Book value
$4.75
EPS (TTM)
$-3.58
52-week high
$13.64
52-week low
$0.76
50-day MA
$0.93
200-day MA
$1.98
Beta
0.89

Analyst view

with an average price target of $256.00.

Shareholding

Insiders
2.03%
Institutions
9.79%

Largest institutional holders

FundStake
Armistice Capital, LLC2.93%
Heights Capital Management Inc0.79%
BOOTHBAY FUND MANAGEMENT, LLC0.61%
Bank of America Corp0.23%
Vanguard Fiduciary Trust Co0.23%
Tower Research Capital LLC0.04%
L1 Global Manager Pty Ltd0.00%
Caitong International Asset Management Co., Limited.0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Bluejay Diagnostics Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.